Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide

Bo YANG,Yang HE,Dong-lin SUN,Yan ZOU,Xi-hu QIN,Bo-hua HUANG

DOI: https://doi.org/10.3321/j.issn:0376-2491.2008.28.004

2008-01-01

Abstract:Objective To investigate whether dendritic cells(DCs)pulsed with mutant K-ras peptide(12-Val)can induce efficiently specific anti-tumor immune response aganist pancreatic cancer.Methods Immature DCs were isolated from the pefipheral blood of a volunteer and were pulsed with synthesized mutant K-ras peptide(YKLVVVGAV).When the DCs were matured the expression rate of Kras antigen epitope on the DC's surface was detected by monoantibody(K-ras-12-Val).Autogeneic and homologous T cells were mixed with the mutant K-ras peptide-pulsed DCs.Human pancreatic cancer cells of the line Patu8988 were mixed with cytotoxic T lymphocytes(CTLs)cultured for 5 days.and the killing eriects of the CTLs on the ceils was assessed by MTY method.Patu8988 cells were iniected subcutaneously into nude mice.cancer cells were obtained from the tumor masses and injected subcutaneously into other nude mice to establish mice models of pancreatic cancer.Then 32 mice with pancreatic cancer were randomly divided into 4 equal groups:control group.K-ras specific CTL intra-tumor injection group,CTL caudal vein injection group,and IL-2 activated non-specific CTL intra-tumor injection group.The tumor size was measure regularly.Immunohistochemistry was used to detect the pathological analysis of the transplanted tumors.Results The mutational epitope(K-ras-12-Val)induced by mutant peptide could be foand on the DCs' suIface efficiently.After co-incubation with the mature DCs pulsed with tumor antigen the autogeneic T cells were activated.the CD8+T cells accounted for(44.8±2.1)%.Without damage the normaI tissue cells,the killing rate of activated K-ras specific CTLs to the tumor cell when Lhe ratios of CTL:Patu8988 cells were 10:1,20:1,and 50:1 were(21.2±1.9)%,(32.4±2.1)%,and(45.7±5.3)% respectively.alJ while the killing efficiency significantly superior to those of the non-specific activated Tlymphocyte(all P<0.05).Eight days after CTL iniection into the nude mice the tumor size of the intratumor injection group was(68±13)mm3,significantly smaller than those of the control group and IL-2 activated non-specific CTL intra-tumor injection group[(87±14)mm3 and(79±19)mm3,both P<0.05].The survival rates of the nude mice of the K-ras specific CTL intra-tumor injection group,CTL caudal vein injection group.and IL-2 activated non-specific CTL intra-tumor injection group were all significantly higher than that of the contml group(all P<0.05),and the survival rate ofthe K-ras specific CTL intra-tumor injection group was significantly higher than that of the IL-2 activated non-specific CTL intra.tumor injection group(P<0.05).Immunohistochemieal staining confirmed that K-ras specific CTL had the ability to move toward tumor.Conclusion DCs pulsed with mutant K-ras peptide(12-Val)induces specific anti-tumor immune response in pancreatic cancer efficiently.